Fertility-female
Conditions
Interventions
Healthy Participants taking no drugs
Group of myoinstol and co enzyme Q10 drugs
Sponsors
Assuit University Hospital
AboTig Hospital
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: • Women aged 21–40 years. • BMI 18–35 kg/m². • Diagnosed with infertility (>1 year). • Undergoing first or second IVF/ICSI cycle. • Normal uterine anatomy. • PCOS. • Poor ovarian responders (as per Bologna criteria). • Normal responder.
Exclusion criteria
Exclusion criteria: • Endometriosis grade III/IV. • Severe male factor infertility. • Age less than 21 or more 40. • BMI less than 18 and more than35. • Use of antioxidants or hormonal therapy in last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effect of combined Myo-Inositol and co enzyme Q10 supplementation on oocyte quality in women undergoing ART., oocyte quality,maturation,cleavage and fertilization rate. | — |
Secondary
| Measure | Time frame |
|---|---|
| • To assess the impact of the combination on oocyte maturation, on cleavage rate and blastocyst rate. • To assess the impact of the combination on fertilization rate. • To assess the impact of the combination on clinical pregnancy rates. • To assess the impact of the combination on live birth rate. | — |
Countries
Egypt
Contacts
Public ContactAhmed Mohamed ;Tarek Abdelradi Abuelhasan Morsy;Abdelsalam farghaly
Professor of Obstetrics and Gynecology . Faculty of Medicine Assuit University;Professor of Obstetrics and Gynecology . Faculty of Medicine Assuit University
Outcome results
None listed